Jun 3, 2026 08:30AM

Jun 3, 2026 08:30AM

Dec 22, 2025 04:48PM

Dec 22, 2025 04:48PM

Dec 18, 2025 09:00AM

Dec 18, 2025 09:00AM

Jul 9, 2025 05:15PM Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering

Jul 8, 2025 04:05PM

Jul 8, 2025 04:05PM

Feb 11, 2025 08:44AM

Feb 11, 2025 08:42AM

Jan 22, 2025 05:27PM

Apr 30, 2024 05:08PM

Apr 23, 2024 01:46PM Form S-3 LIXTE BIOTECHNOLOGY HOLD

Aug 11, 2023 04:21PM

Jul 20, 2023 04:05PM

Jul 18, 2023 08:02AM

Jul 18, 2023 08:00AM

Nov 22, 2022 10:19AM

Apr 14, 2022 06:45PM

Apr 14, 2022 06:45PM LIXTE Biotechnology Announces the Closing of $5.8 Million Registered Direct Offering Priced At-The-Market

Apr 14, 2022 02:54PM

Apr 13, 2022 09:00AM

Apr 13, 2022 08:30AM

Apr 12, 2022 01:54PM

Apr 12, 2022 01:52PM

Apr 12, 2022 01:52PM

Oct 13, 2021 09:28AM Lixte Biotechnology Holdings, Inc. (LIXT) Collaborates with Netherlands Cancer Institute and Oncode Institute to Identify Promising Drug Combinations for LB-100 for Cancer Treatment

Mar 2, 2021 06:38PM

Mar 2, 2021 03:41PM

Mar 2, 2021 10:30AM

Mar 2, 2021 10:30AM

Mar 1, 2021 08:46AM

Mar 1, 2021 08:45AM

Mar 1, 2021 08:45AM Lixte Biotechnology Announces $4.19 Million Registered Direct Offering

Jan 26, 2021 12:03PM

70,546 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All